اکثر مکاتبات کومش از طریق ایمیل سایت می باشد. لطفا Spam ایمیل خود را نیز چک نمایید.
   [Home ] [Archive]   [ فارسی ]  
:: ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
Subscription::
Contact us::
Site Facilities::
Webmail::
Editorial Board::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 21, Issue 1 (زمستان 1397) ::
Koomesh 1397, 21(1): 140-144 Back to browse issues page
Effects of IL-4 and RANKL synergism on survival of peripheral blood monocytes in patients with giant cell granuloma
Leila Mohamed Khosroshahi , A. li Mohammadi , Sona Rafieyan , A. li Aghbali , A. li Aghebati , A. li Fotouhi , Leili Aghebati-Maleki , Behzad Baradaran
Abstract:   (3955 Views)
Introduction: Giant cell granuloma is a non-neoplastic lesion that is characterized by the fact that granulation tissue proliferation has many multiples of giant cells.Considering the role of IL-4 and RANKL in the pathogens of the disease in this study, we investigated the synergism effects of these two factors on the survival of monocytes isolated from peripheral blood in patients with giant cell granuloma compared with healthy subjects. Materials and Methods: After blood collection of patients with giant cell granuloma and healthy individuals, peripheral blood mononuclear cells were isolated by ficoll density gradient centrifugation and the monocytes were isolated using human Monocyte Isolation Kit II. Isolated monocytes were then cultured in the absence or presence of IL-4 and RANKL (10 and 20 ng/mL) for five days. After morphological examination by inverted microscope, following MTT assay was performed to determine proliferation. Results: The results showed a difference in the survival of monocytes in comparison between the patient group and the healthy group after the treatment period. On the other hand, in both patient and healthy groups, the number of treated cells was higher in comparison to untreated control groups, which in the groups treated with morphological evidence showed a change in favor of the formation of giant cells. Both IL-4 and RANKL factors increased the survival of monocytes in comparison with the control group. Conclusion: The results of this study showed the increased survival and the number of monocytes isolated from peripheral blood in patients with giant cell granuloma by IL-4 and RANKL factors, with the creation of morphology of giant cell. These results indicate that IL-4 and RANKL factors are involved in the onset of malignant disease
Keywords: IL-4, Monocyte, RANKL, Giant Cell Granuloma
Full-Text [PDF 1112 kb]   (722 Downloads)    
Type of Study: Research | Subject: General
Received: 2017/07/19 | Accepted: 2018/06/27 | Published: 2019/01/7
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohamed Khosroshahi L, Mohammadi A L, Rafieyan S, Aghbali A L, Aghebati A L, Fotouhi A L, et al . Effects of IL-4 and RANKL synergism on survival of peripheral blood monocytes in patients with giant cell granuloma. Koomesh 1397; 21 (1) :140-144
URL: http://koomeshjournal.semums.ac.ir/article-1-4145-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 1 (زمستان 1397) Back to browse issues page
کومش Koomesh
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645